Murae Organisor

1.23
+0.05
(4.24%)
ann
There are 2 new updates from the company20 hours ago
Viewcross
right
Market Cap
114.35 Cr
EPS
0.00
PE Ratio
23.60
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
2.73
52 Week Low
1.04
PB Ratio
0.35
Debt to Equity
0.12
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,765.10
#1 4,23,506.62
36.24
#1 49,887.20
12.06
#1 9,648
13.77
52.54
6,087.00
1,61,590.72
78.92
8,184.00
0.89
1,600
#1 64.53
61.32
1,486.20
1,20,027.73
24.42
26,520.70
14.17
4,155
47.38
50.90
3,257.10
1,10,235.06
59.79
10,785.70
11.59
1,656
13.54
54.71
2,459.90
1,01,490.19
49.11
10,615.60
19.57
1,942
-16.38
48.65
1,151.00
96,045.81
#1 18.02
28,905.40
12.36
5,578
1.69
48.72
2,052.90
93,723.29
32.97
20,141.50
#1 19.94
1,936
38.82
52.90
885.95
89,147.30
19.68
19,831.50
13.82
3,831
29.92
52.04
1,185.20
68,836.61
19.72
29,559.20
17.55
3,169
-10.04
51.90
30,180.00
64,130.39
48.19
6,097.20
10.80
1,201
16.01
51.66
Growth Rate
Revenue Growth
-75.00 %
Net Income Growth
-95.00 %
Cash Flow Change
-6,223.08 %
ROE
-99.06 %
ROCE
-96.36 %
EBITDA Margin (Avg.)
-50.21 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
9
19
24
36
51
57
50
29
16
4
340
Expenses
9
18
23
34
47
54
49
26
13
4
334
EBITDA
0
1
1
2
3
4
1
3
3
0
6
Operating Profit %
3 %
3 %
2 %
4 %
7 %
2 %
-19 %
-21 %
7 %
-44 %
-22 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
1
1
1
1
1
0
0
0
0
Profit Before Tax
0
0
0
1
2
2
0
3
3
0
6
Tax
0
0
0
0
1
1
0
1
1
0
2
Net Profit
0
0
0
1
2
2
0
2
2
0
5
EPS in ₹
11.26
10.07
5.27
29.62
53.83
2.94
0.01
0.36
0.32
0.00
0.10

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
5
9
11
20
23
36
28
29
29
120
Fixed Assets
0
0
0
0
1
1
1
1
1
0
Current Assets
5
9
11
19
23
32
27
28
28
120
Capital Work in Progress
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
5
9
11
19
23
35
27
28
28
120
Total Liabilities
5
9
11
20
23
36
28
29
29
120
Current Liabilities
3
7
9
13
15
20
11
12
10
64
Non Current Liabilities
1
0
1
2
3
1
2
0
0
0
Total Equity
1
1
2
5
6
14
15
17
19
56
Reserve & Surplus
0
1
1
4
6
8
8
4
6
6
Share Capital
0
0
0
0
0
6
6
12
12
49

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
0
-0
-0
0
-0
-1
0
0
12
Investing Activities
0
-0
0
-0
-0
-4
3
0
0
-1
Operating Activities
-2
-0
0
-7
-1
-4
-7
3
0
-16
Financing Activities
2
1
-0
7
1
7
3
-3
-0
28

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
May 2024
Jun 2024
Aug 2024
Sept 2024
Dec 2024
Jan 2025
Mar 2025
Promoter
70.04 %
70.04 %
70.04 %
70.04 %
50.21 %
37.57 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
29.33 %
28.50 %
28.39 %
26.56 %
45.47 %
56.92 %
95.48 %
95.05 %
95.01 %
63.97 %
95.47 %
95.34 %
92.07 %
91.70 %
91.62 %
47.62 %
47.57 %
47.12 %
60.15 %
60.02 %
Others
0.63 %
1.46 %
1.57 %
3.40 %
4.32 %
5.50 %
4.52 %
4.95 %
4.99 %
36.03 %
4.53 %
4.66 %
7.93 %
8.30 %
8.38 %
52.38 %
52.43 %
52.88 %
39.85 %
39.98 %
No of Share Holders
46
91
242
10,710
24,944
26,192
30,201
31,093
30,714
30,869
48,146
52,415
58,634
58,445
55,791
56,390
54,654
62,098
60,844
78,899

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
28 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Jan 2025 2.03 1.80
10 Jan 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
10 Jan 2025 2.15 1.86
19 Dec 2024 RIGHTS Rights
1:3
19 Dec 2024 2.13 2.15
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 1.37 1.29
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 1.29 1.23
24 Apr 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
24 Apr 2024 1.40 1.62
20 Mar 2024 CHANGE OF NAME Change Of Name
NA
20 Mar 2024 1.75 1.75
RIGHTS Rights
4:1
10 Apr 2023 1.81 0.00
10 Aug 2021 BONUS Bonus
1:1
09 Aug 2021 8.66 12.21

Announcements

Announcement under Regulation 30 (LODR)-Change in Registered Office Address20 hours ago
Board Meeting Outcome for Outcome Of The Board Meeting Held On Today I.E. 7Th May 202520 hours ago
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot8 days ago
Board Meeting Outcome for Outcome Of Board Meeting Dated April 24Th 2025 Along With Additional Details As Per SEBI Circular Dated 13.07.2023 Regarding Disclosure Of Material Events/ Information By Listed Entities Under Regulations 30 And 30A Of SEBI (LApr 24, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 22, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Consider Stock Split Under SEBI (LODR) Regulations 2015Apr 21, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerApr 04, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorApr 01, 2025
Annoucement Under Regulation 30 Of SEBI (LODR) Regulations 2015- Reconstitution Of Committee.Mar 29, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateMar 29, 2025
Board Meeting Outcome for Outcome And Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 29, 2025
Closure of Trading WindowMar 29, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateMar 21, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorMar 21, 2025
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Feb 20, 2025
Integrated Filing (Financial)Feb 14, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Thursday 13Th February 2025Feb 13, 2025
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 07, 2025
Rumour verification - Regulation 30(11)Jan 31, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 29, 2025
Integrated Filing (Financial)Jan 28, 2025
Submission Of Unaudited Financial Results For The Quarter And Nine Months Ended On 31St December 2024 Along With Limited Review ReportJan 28, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On Today I.E. 28Th January 2025Jan 28, 2025
Intimation Of Trading Approval Received For Rights Issue Of Fully Paid-Up Equity Shares By Murae Organisor Limited (Formerly Known As Earum Pharmaceuticals Limited) (The Company) Under Regulation 30 OJan 24, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday 28Th January 2025Jan 23, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 23, 2025
Board Meeting Outcome for Rights Issue Committee Approves Allotment Of Shares W.R.T. Rights Issue Of The CompanyJan 17, 2025
Submission Of Voting Results Of Extra Ordinary General Meeting Of The Company Under Regulation 44(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 13, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJan 13, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2025
Shareholder Meeting / Postal Ballot-Outcome of EGMJan 10, 2025
Closure of Trading WindowDec 31, 2024
Addendum To Notice Of The Extra-Ordinary General Meeting (EGM) Of Murae Organisor Limited (Formerly Known As Earum Pharmaceuticals Limited) To Be Held On Friday 10Th January 2025 At 03:00 P.M. ThroughDec 23, 2024
Intimation Of Record Date For Issue Of Equity Shares On Rights ('Rights Issue')Dec 13, 2024
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sDec 13, 2024
Board Meeting Outcome for Intimation And Outcome Of Board Meeting Held Today I.E., 13Th December, 2024 As Per The Regulation 30 Of SEBI (LODR) Regulation, 2015Dec 13, 2024
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Friday, 13Th December, 2024Dec 10, 2024
Intimation Of In-Principle Approval Received For Rights Issue Of Fully Paid-Up Equity Shares By Murae Organisor Limited (Formerly Known As Earum Pharmaceuticals Limited) ('The Company') Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulations, 2015.Dec 02, 2024
Announcement under Regulation 30 (LODR)-Resignation of Statutory AuditorsNov 15, 2024
Submission Of Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September, 2024 Along With Limited Review ReportNov 15, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On Today I.E. 14Th November, 2024Nov 15, 2024
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday, 14Th November, 2024Nov 09, 2024
Board Meeting Outcome for Outcome And Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Nov 09, 2024
Board Meeting Outcome for Revised OutcomeOct 28, 2024
Intimation Of Trading Approval Received For Preferential Issue Of Fully Paid-Up Equity Shares Pursuant To Conversion Of Warrants By Murae Organisor Limited (Formerly Known As Earum Pharmaceuticals Limited) ('The Company') Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirements)Oct 22, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E., 15Th October, 2024Oct 15, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 15, 2024
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday, 15Th October, 2024Oct 10, 2024
Voting Results As Per Regulation 44(3) Of SEBI(LODR) Regulation, 2015Oct 03, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportOct 03, 2024

Technical Indicators

RSI(14)
Neutral
31.57
ATR(14)
Volatile
0.09
STOCH(9,6)
Oversold
17.65
STOCH RSI(14)
Neutral
33.33
MACD(12,26)
Bearish
-0.01
ADX(14)
Weak Trend
17.57
UO(9)
Bullish
20.11
ROC(12)
Downtrend And Accelerating
-10.61
WillR(14)
Oversold
-92.16